ChemicalBook >> CAS DataBase List >>Senaparib

Senaparib

CAS No.
1401682-78-7
Chemical Name:
Senaparib
Synonyms
IMP4297;IMP 4297;IMP-4297;Senaparib;Senaparib (IMP-4297);Rotundine Impurity 13;inhibit,poly ADP ribose polymerase,IMP 4297,Inhibitor,breast,pancreatic,IMP-4297,Senaparib,PARP,cancer,PCa;2,4(1H,3H)-Quinazolinedione, 5-fluoro-1-[[4-fluoro-3-[[4-(2-pyrimidinyl)-1-piperazinyl]carbonyl]phenyl]methyl]-
CBNumber:
CB68080026
Molecular Formula:
C24H20F2N6O3
Molecular Weight:
478.45
MDL Number:
MFCD32878274
MOL File:
1401682-78-7.mol
Last updated:2024-08-01 14:43:30

Senaparib Properties

storage temp. Store at -20°C
solubility DMSO : 83.33 mg/mL (174.17 mM; Need ultrasonic)
form Solid
color White to off-white
FDA UNII MNZ4OP95CF
NCI Drug Dictionary senaparib

Senaparib price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0138656 Senaparib 99.44% 1401682-78-7 5mg $110 2021-12-16 Buy
ChemScene CS-0138656 Senaparib 99.44% 1401682-78-7 10mg $190 2021-12-16 Buy
ChemScene CS-0138656 Senaparib 99.44% 1401682-78-7 25mg $350 2021-12-16 Buy
ChemScene CS-0138656 Senaparib 99.44% 1401682-78-7 50mg $550 2021-12-16 Buy
ChemScene CS-0138656 Senaparib 99.44% 1401682-78-7 100mg $950 2021-12-16 Buy
Product number Packaging Price Buy
CS-0138656 5mg $110 Buy
CS-0138656 10mg $190 Buy
CS-0138656 25mg $350 Buy
CS-0138656 50mg $550 Buy
CS-0138656 100mg $950 Buy

Senaparib Chemical Properties,Uses,Production

Clinical research

Senaparib is a PARP inhibitor that demonstrated antitumor activity in patients with solid tumours, including ovarian cancer, in phase 1 studies. The multicenter, double-blind, phase 3 trial FLAMES randomized (2:1) 404 females with advanced ovarian cancer (International Federation of Gynecology and Obstetrics stage III–IV) and response to first-line platinum-based chemotherapy to senaparib 100 mg (n = 271) or placebo (n = 133) orally once daily for up to 2 years. The primary endpoint was progression-free survival assessed by a blinded independent central review. At the prespecified interim analysis, the median progression-free survival was not reached with senaparib and was 13.6 months with placebo (hazard ratio 0.43, 95% confidence interval 0.32–0.58; P < 0.0001). The benefit of senaparib over placebo was consistent in the subgroups defined by BRCA1 and BRCA2 mutation or homologous recombination status. Grade ≥3 treatment-emergent adverse events occurred in 179 (66%) and 27 (20%) patients, respectively.

Description

Senaparib is a novel and potent PARP1 inhibitor with a unique chemical structure and high inhibitory activity. Research has found that Senaparib not only effectively inhibits the enzymatic activity of PARP1 and PARP2 but also induces the "trapping" of PARP1 on DNA, leading to the stalling of DNA replication forks and double-strand DNA breaks, ultimately causing cell death. This "trapping" effect is considered a key factor in the therapeutic efficacy of PARP1 inhibitors.

Senaparib Preparation Products And Raw materials

Raw materials

Preparation Products

Senaparib Suppliers

Global( 21)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd
+8618327326525 masar@topule.com China 8474 58
LEAPCHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 43348 58
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. 17702719238 17702719238 sales@sun-shinechem.com China 950 64
Shanghai Biolang biotechnology Co.,Ltd 17764003753 2326587775@qq.com China 188 55
Shanghai Biolang biotechnology Co.,Ltd 17764003753 2326587775@qq.com China 188 55
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994 2853530910@QQ.com China 8014 62
Shanghai Rechem science Co., Ltd. 21-31433387 15618786686 sales@rechemscience.com China 2970 58
Wuhan Sun-shine Bio-technology Corporation Limited +86-027-6552-2453 sales@sun-shinechem.com China 727 58
Guangzhou Younan Technology Co., Ltd 020-020-82000279 18988968278 sales@ubiochem.com China 4297 58
Senaparib 2,4(1H,3H)-Quinazolinedione, 5-fluoro-1-[[4-fluoro-3-[[4-(2-pyrimidinyl)-1-piperazinyl]carbonyl]phenyl]methyl]- IMP 4297 IMP4297 IMP-4297 inhibit,poly ADP ribose polymerase,IMP 4297,Inhibitor,breast,pancreatic,IMP-4297,Senaparib,PARP,cancer,PCa Rotundine Impurity 13 Senaparib (IMP-4297) 1401682-78-7 C24H20F2N6O3